Mid and South Essex NHS Foundation Trust

Profile narrative

Mid and South Essex NHS Foundation Trust, also known by its abbreviation MSE, is a National Health Service organisation operating in the United Kingdom. It runs three major hospital sites: Broomfield, Basildon, and Southend, which collectively provide secondary and acute healthcare services to populations across the mid and south Essex region. As an NHS Foundation Trust, it operates within the public healthcare framework of England, delivering services such as emergency care, surgery, outpatient treatment, maternity services, and diagnostic testing, including blood, urine, and tissue sample analysis. The Trust works alongside other NHS bodies and external service providers to deliver patient care, and it relies on third-party contractors for certain specialised functions such as pathology and laboratory testing. Synnovis, a third-party testing provider, has historically been one such partner handling pathology services linked to the Trust's hospitals.

In terms of scale, the Trust serves a wide geographic catchment across Essex through its three main hospital sites, though precise figures for patient volumes, workforce size, or bed capacity are not detailed in the available material. The available source material does, however, highlight its position as a multi-site acute care provider within the English NHS system, with a footprint that makes it a significant regional healthcare institution. The Trust operates under the regulatory oversight of NHS England and is subject to the standards and reporting requirements that apply to NHS Foundation Trusts, including financial accountability and care quality obligations.

A notable distinguishing attribute of the Trust, at least as evident from the available incident information, is its exposure to cyber risk through its dependence on third-party suppliers. In June 2024, Mid and South Essex NHS Foundation Trust was identified as one of multiple NHS trusts affected by a cyber attack on Synnovis. The Russia-based criminal group Qilin claimed responsibility for that attack, which resulted in the theft of approximately 2,380 patient records linked to the Trust. Stolen information potentially included names, dates of birth, patient numbers, NHS numbers, postcodes, and test results from pathology samples. Synnovis later stated that the data appeared to have been taken "in haste and in a random manner" and that there was no evidence of malicious use, although the stolen information was published on the dark web. The Trust confirmed it was notified months after the breach occurred and engaged cybersecurity experts to review and strengthen its own systems, while preparing to contact those patients whose data had been compromised.

Structurally, the Trust functions as an independent statutory body within the NHS, holding Foundation Trust status which provides it with a degree of operational and financial autonomy compared to directly managed NHS trusts. It is not described in the available material as a subsidiary of another organisation, nor does it appear to operate as a parent entity over other bodies beyond its own hospital sites. Its engagement with external partners such as Synnovis reflects a broader NHS trend of outsourcing specialised diagnostic services, which has implications for data governance and incident response, as illustrated by the 2024 breach.

Incidents

1 incident linked to this organisation.